ClinicalTrials.Veeva

Menu

Acute Phase Proteins as Early Markers in Sepsis

University of Zurich (UZH) logo

University of Zurich (UZH)

Status

Unknown

Conditions

Sepsis

Treatments

Procedure: No intervention

Study type

Observational

Funder types

Other

Identifiers

NCT00641355
StV 26-2007

Details and patient eligibility

About

Monitoring of different serumproteins after severe trauma and during trauma-induced sepsis.

  • Trial with surgical intervention

Enrollment

15 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with severe trauma (ISS score > 16), both genders, patients on ICU

Exclusion criteria

  • Moribund patients (pH <7,1, lactate >15mmol, Basedeficit > 15mEq/L, severe heart or liver injuries, GCS never over 5 after trauma)
  • Severe head injuries (AIS head >4)
  • Patient with severe infectious diseases, or diseases which severely affect the immune system (diabetes, Alkohol or nicotine abuse)
  • Non-german speaking patients

Trial contacts and locations

1

Loading...

Central trial contact

01 Studienregister MasterAdmins

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems